Is HRAS p.Ile142Phe (c.424A>T) pathogenic?

HRAS p.Ile142Phe (c.424A>T) is classified Uncertain significance in HRAS (ClinVar, Single submitter, 1 submitter; last evaluated 2024-07-26). AlphaMissense: ambiguous (0.4344); Absent from gnomAD v4.1; Associated with Costello syndrome.

What condition is associated with HRAS p.Ile142Phe (c.424A>T)?

HRAS p.Ile142Phe (c.424A>T) is associated with Costello syndrome (ClinVar).

How common is HRAS p.Ile142Phe (c.424A>T) in the general population?

HRAS p.Ile142Phe (c.424A>T) is absent from gnomAD v4.1 (gnomAD).

What do computational predictors say about HRAS p.Ile142Phe (c.424A>T)?

AlphaMissense predicts ambiguous (score 0.4344) — an in-silico prediction, not a clinical call.

HRAS p.Ile142Phe

c.424A>T · rs1564788848 · VCV2416003

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

ambiguous

0.4344 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

0/2 damaging

REVEL, SaProt · AlphaMissense no call

Conditions

Costello syndrome

Computational evidence

Protein change
AlphaMissense	0.4344	ambiguous
REVEL	0.282	benign-leaning
SaProt	LLR -4.97	tolerated
⇒ REVEL and SaProt both call this tolerated; AlphaMissense makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -0.082	GERP 1, phastCons 0.87
Regional constraint	o/e 1.01	unconstrained · MANE · 1,164 bp · p 0.94 · regional, not allelic
Overall
CADD	21.6	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: HRAS
Protein: p.Ile142Phe
Coding: c.424A>T
MANE Select: NM_005343
dbSNP: rs1564788848
Type: single nucleotide variant
Location: chr11:533479 (GRCh38)
Gene constraint: LOEUF 0.893 · pLI 0.02 · ClinGen HI 0/3 (gnomAD)
Structure: AlphaFold pLDDT 92.50 · 256 PDB
Residue 142: a β-strand

Full HRAS gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Costello syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

HRAS p.Ile142Leu Uncertain significance ★★ ⚠ same residue
HRAS p.Ile142Met Uncertain significance ★★ ⚠ same residue
HRAS p.Ile142Thr Uncertain significance ★ ⚠ same residue
HRAS p.Ile142Val Uncertain significance ★ ⚠ same residue
HRAS p.Ile142= Likely benign ★ same residue
HRAS p.Ile142del Uncertain significance ★ same residue
HRAS p.Ala59Thr Likely pathogenic ★★★ same condition
HRAS p.Gly12Ser Pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hras-p-ile142phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown